基本信息
浏览量:1
职业迁徙
个人简介
Dr. Bent's main research interest is the evaluation of the safety and efficacy of herbal remedies and dietary supplements. He served as the project director for one of the first large randomized controlled trials of saw palmetto for enlarged prostate, which gained international recognition for demonstrating that this commonly used herb was no more effective than placebo. Dr. Bent has also served as the principal investigator or co-investigator of several other large randomized controlled trials, including a study of a Chinese herbal remedy used to treat fatigue in the elderly and an internet-based study examining the efficacy of the herbs valerian (for sleep) and kava (for anxiety). Recently, Dr. Bent has conducted clinical trials of complementary and alternative therapies in children with autism, including studies of omega-3 fatty acids, methyl B12, sulforaphane, and vitamin D. Dr. Bent was also the Principal Investigator of the first-ever fully internet-based randomized controlled trial of a pharmaceutical drug and the first internet-based trial of a treatment (omega-3 fatty acids) conducted in children with autism. He plans to further develop internet-based technology to speed the testing of promising new therapies. Dr. Bent is an expert in evidence-based medicine and ambulatory care, and has coauthored textbooks in both areas.
研究兴趣
论文共 94 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of health and rehabilitation sciencesno. 2 (2023): 1-10
Bushra Hossain,Stephen Bent,Felicia Widjaja,China I. Parenteau, Christa Watson Pereira, Marilu Gorno-Tempini,Robert L. Hendren
Salomeh Keyhani,J Daniel Kelly,Stephen Bent,W John Boscardin,Michael G Shlipak, Sam Leonard,Ann Abraham,Emily Lum,Nicholas Lau,Charles Austin,Catherine E Oldenburg, Allan Zillich,
Stephen Bent, Martin J O'Malley
加载更多
作者统计
#Papers: 95
#Citation: 7940
H-Index: 39
G-Index: 81
Sociability: 5
Diversity: 3
Activity: 18
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn